†These authors contributed equally.
Academic Editor: Ayse Seyhan
Objective: Globally, the prevalence of urinary incontinence (UI) in women is estimated to be in the range of 25% to 45%. Different types of UI exist, being the most frequent ones stress UI, urgency UI and mixed UI. Being affected by UI is associated with a higher risk of sexual inactivity, regardless of its type. Mechanism: It is estimated that 5–38% patients with UI are sexually inactive due to UI, whereas 25–38% sexually active women would restrict their sexual activity due to UI. The prevalence of sexual dysfunction within sexually active women with UI is 23–56%. Findings in Brief: In patients with UI, the most frequent sexual dysfunctions are dyspareunia (44%), female sexual interest/arousal disorder (34%) and orgasmic disorder (11%). Therefore, UI has a negative impact on the sexual function of sexually active women with UI. Coital incontinence is defined as the complaint of involuntary loss of urine during or after intercourse. UI with penetration represents any complaint of involuntary loss of urine with vaginal stimulation (either with a sexual toy, manually or with penetration). Orgasmic UI refers to any complaint of involuntary loss of urine occurring at orgasm, regardless of the sexual behaviour that has triggered it. Due to the high prevalence of coital UI (50–60%) in the female population and its strongly negative impact on women’s sexuality, patients should be specifically asked for coital UI in the gynecologic visits. Conclusions: UI affects between one in four and one in two women and had a negative impact on quality of life. Not only UI has an impact on female sexuality, but also different treatments which are offered to treat it can play a role. The reduction of sexual problems with pelvic floor muscle training in women with stress UI has been proved, being the rate of sexual activity doubled. A significant improvement of the overactive bladder associated to urgency UI and female sexual function has been described after the pharmacological treatment or botulinum toxin. Finally, significant improvement of the sexual function has also been found after midurethral slings for stress UI, as well as for coital UI.
According to the International Continence Society, UI is a condition defined by involuntary loss of urine. Even though UI prevalence in women widely varies depending on the country [1], the majority of studies globally report numbers in the range of 25% to 45% [2]. Different types of UI exist, being the most frequent ones stress UI, urgency UI and mixed UI. Stress UI is defined by involuntary leakage of urine on effort, physical exertion, sneezing or coughing, with a prevalence in the female population estimated between 10% and 39%. Urgency UI consists of involuntary loss of urine associated with urgency (complaint of sudden, compelling desire to pass urine which is difficult to defer) and approximately affects 1–7% women. Mixed UI represents the association between stress UI and urgency UI and its prevalence is 7–25% [2, 3].
Despite the fact that UI is not a life-threatening condition, quality of life is negatively affected by it. A cross-sectional study including 556 women assessed the impact of UI on quality of life by means of the following validated questionnaires: Medical Outcomes Study 36-item Short-Form Health Survey (SF-36), International Consultation Incontinence Questionnaire Short-Form (ICIQ-SF), King’s Health Questionnaire (KHQ), and Pelvic Organ Prolapse Incontinence Sexual Questionnaire (PISQ-12). This study showed that all types of UI interfere in the score of both the general (SF-36) and specific (KHQ and ICIQ-SF) quality of life questionnaires, being women with mixed UI the most affected in this way by their condition [4]. In this line, a study performed in a total of 391 women who were seeking help for all types of UI in a tertiary hospital demonstrated that even mild urinary leakage significantly reduces the quality of life, being less affected by stress UI than by urgency or mixed UI [5].
Quality of life refers to the individual’s perception of joy with their own life events, in relation to their goals, expectations, standards and concerns. Therefore, it is important to consider that UI, with its potential impact on the quality of life, may negatively influence its multiple dimensions, thus altering the physical, social, emotional and sexual wellbeing of the individual.
Data from published studies shows sexual activity is affected in all the types of UI [6]. All types of UI are associated with a higher risk of sexual inactivity. A case-control study [7] in women from 30 to 60 years old with stress UI, urgency UI or mixed UI in comparison with women without UI, reported a higher rate of sexual inactivity (including penetration, oral sex and masturbation) within the incontinent group (53 vs 29%). Furthermore, these authors found that age, civil status and UI were independent predictive factors for sexual inactivity.
It is estimated that 5–38% patients with UI are sexually inactive due to UI, whereas 25–38% sexually active women would restrict their sexual activity due to UI [6]. The restriction on the sexual activity tends to be due to the fear of incontinence or to the negative emotions such as shame during intercourse, mostly derived from a weakened self-image and self-reliance by this condition [8]. Other reported causes of sexual inactivity are: dyspareunia, nocturnal enuresis, the need of sleeping in separated beds, coital UI or the absence of a partner [6].
The prevalence of sexual dysfunction within sexually active women with UI is 23–56% [6]. A correlation between the global quality of life of a woman with UI and the impact of her urinary symptoms on her sexual life has been described by Jha et al. [9], independently of the urodynamic diagnosis (stress incontinence, detrusor overactivity and mixed incontinence).
Salonia et al. [10] conducted a study which included 227 women who complained of UI and/or lower urinary tract symptoms. They were assessed with a comprehensive history that included validated questionnaires, a physical examination, an urodynamic testing and the Female Sexual Function Index (FSFI) for the evaluation of the sexual function [10]. In 46% of these patients with UI a sexual dysfunction was diagnosed, and the most frequent sexual dysfunctions were dyspareunia (44%), female sexual interest/arousal disorder (34%) and orgasmic disorder (11%) [10]. Patients with UI more frequently have sexual fantasies related with the fear to suffer from an episode of urine leakage during intercourse. Such fear may trigger sexual anxiety, a decrease in the sexual activity, low desire and arousal, dyspareunia and a decrease in the orgasmic frequency [10, 11].
Regarding the impact of the UI on the partner relationship, a study including 206 women with UI and/or urgency, which focused on the 99 sexually active heterosexual couples who wanted to participate, showed that 49% of the women reported concerns about having urinary leakage during sexual activity, whereas most of their male partners (94%) did not [12].
Therefore, as stated in the systematic review of Pinheiro et al. [13], UI has a negative impact on the sexual function. It is probable that this interference contributes, directly or indirectly, to the avoidance of sexual activity. Nevertheless, the way in which this influence occurs is not yet clear [13].
When comparing the different types of UI, the majority of studies suggest patients with mixed UI more frequently suffer from sexual dysfunctions, followed by patients with urgency UI and patients with stress UI [6]. Focalising on the urgency UI, a case-control study with 135 sexually active women with overactive bladder and detrusor overactivity and 112 healthy women, reported a significantly lower score both in the global sexual function and its dimensions in the case group, using a generic sexual questionnaire (FSFI) [14].
Regarding stress UI, qualitative studies evaluate female’s sexuality affectation secondary to an altered body image. A study published by Roos [15] reported a 60% rate of negative autoevaluation of sexual life within sexually active women with partner waiting for an antiincontinence surgery. Women presented with an affected corporal image and an alteration of multiple sexuality dimensions such as motivation, arousal and orgasm. Furthermore, the presence of coital incontinence, or the fear of this condition, was associated with interest, arousal, orgasm and pain disorders.
Taking the above information into consideration, the evaluation of UI during sexual activity seems an important issue to determine whether this symptom leads to a major impact on sexuality of incontinent women.
Traditionally, the study of UI during sexual activity has been focalised on coital incontinence, defined as the complaint of involuntary loss of urine occurring during or after vaginal intercourse [16]. Coital UI has an estimated prevalence of 50–60% within incontinent sexually active women, according to studies mainly performed in heterosexual female population [9, 17]. An epidemiological international multicenter study which included 1041 sexually active women with UI from Italy, Greece, the United States and Egypt, observed that the prevalence of coital UI was 53.8% [18].
In a cross-sectional multicentric Spanish study conducted in sexually active women who attended the gynecologist seeking treatment for UI and/or overactive bladder, at least one out of three of them had coital UI [11]. Forty per cent of these women reported an either moderate or big impact on their quality of life measured by means of the specific questionnaire King’s Health Questionnaire. Observing in detail the answers given to the items about impact on couple and sexual life comprised in the personal relations dimension, it is possible to verify that women with coital UI have higher scores than those without it [11]. Furthermore, in the multiple regression model in which age and body mass index were entered along with all the variables of urinary symptoms, the only variable that demonstrated independent association with a worse quality of life was coital UI. For this reason, it was concluded that more research is needed about the presence of this symptom in women with urinary symptoms and its relationship with patient-perceived severity and sexual dysfunction [11]. Similar to this results, Illiano et al. [18] found that women with coital UI were more affected by UI on their daily life compared to women without coital UI.
A higher prevalence of coital UI (60%) was reported in another cross-sectional
study conducted in women with UI who subsequently underwent an urodynamic
assessment [9]. No difference in the prevalence of coital UI when the different
urodynamic diagnosis (stress incontinence, detrusor overactivity and mixed
incontinence) were compared, whereas women with normal urodynamic findings were
less likely to experience UI during coital activity (p = 0.035). The
physiopathological mechanism underlying coital UI is still controversial.
Classically, this symptom has been divided into that occurring with penetration
and that occurring at orgasm. Coital UI occurring with penetration has been
associated with urodynamic stress UI and coital UI occurring at orgasm has been
associated with urodynamic detrusor overactivity [6, 19]. Nevertheless, more
recent studies have suggested the association between coital UI and urethral
sphincter deficiency [18, 20, 21], as an association between orgasmic UI and
urodynamic stress incontinence by intrinsic sphincter deficiency has been
observed [18, 21]. Concretely, Lau et al. [20] conducted an observational
study with 505 sexually active women with UI in which univariate analysis both a
higher body mass index and a lower maximal urethral closure pressure (
In accordance with the current terminology of the International Continence Society (ICS)/International Urogynecological Association (IUGA) [16] all women can be evaluated with the new definitions, regardless of their sexual orientation and the existence or not of a partnership. At present, UI with penetration represents any complaint of involuntary loss of urine with vaginal stimulation (either with a sexual toy, manually or with penetration). Orgasmic UI refers to any complaint of involuntary loss of urine occurring at orgasm, regardless of the sexual behaviour that has triggered it.
On the other hand, it is important to stablish an appropriate differential diagnosis between fluids which are expelled during the female sexual response, either during arousal and/or orgasm [22]. Vaginal lubrication is a blood plasma ultrafiltrate of variable amount, representing a transvaginal transudate which increments with sexual stimulation and correlates with the arousal phase of the sexual response. Female ejaculation is another fluid that has been described which occurs during orgasm. It consists of the secretion of a few milliliters of a dense and milky liquid through the urethra, being originated in the paraurethral (Skene’s) glands, which are considered to be the female prostate or G spot for some authors, as it contains prostate specific antigen (PSA) [23]. However, at orgasm, another fluid can be expelled: squirting or gushing. It is defined as an involuntary expulsion of a large quantity of diluted urine during sexual stimulation of the clitoro-urethro-vaginal complex. Therefore, both the female ejaculation and squirting are expelled through the urethra, but their origin (paraurethral glands and bladder, respectively) and, as a consequence, composition, is different. They can be distinguished because squirting is a clear and watery liquid while female ejaculation tends to be a milky substance. These three physiological processes can occur either isolatedly or coexist in some women. All of them are considered a positive phenomenon which improves the sexual life of both the woman herself and her sexual partners [22].
Conversely, women with UI with concomitant coital UI negatively experience this specific symptom, which has an influence in different dimensions of the quality of life [24, 25] (e.g., emotional, relational and sexual). In relation to this, Illiano et al. [18] showed that coital UI was associated with increased severity of UI according to the ICIQ-SF scores, as well as with higher impact on the quality and frequency of sexual activity. Due to the high prevalence of coital UI in the female population and its strongly negative impact on women’s sexuality, patients should be specifically asked for coital UI in the gynecologic visits [17].
Not only UI has an impact on female sexuality, but also different treatments which are offered to treat it can play a role. Conservative measures (lifestyle modifications and pelvic floor muscle training), medicines and surgery are the most frequently used treatments for UI. Other treatments which tend to be used in refractory cases are intravesical injection of botulinum toxin, neuromodulation of the sacral nerve and posterior tibial nerve stimulation.
The female sexual function is inherently complex, as it involves an interplay of multiple physical, hormonal, emotional, contextual and sociocultural factors, among others which have been implicated. Taking the physiology of the sexual response into account, pelvic floor muscles are considered to play an important role in both the female arousal and orgasm [26, 27].
Different studies have described an association between pelvic floor muscle function and better rates of sexual activity and sexual function in women with pelvic floor dysfunctions, even though causality has not been stablished due to a lack of randomized studies. In a multicenter study of 585 women with pelvic floor disorders from the United States and the United Kingdom it was observed that women with a strong pelvic floor were more likely to report sexual activity than women with weak strength, but no differences were found between women with normal and hypoactive pelvic floor tone [28]. In this line, the reduction of sexual problems with pelvic floor muscle training in women with stress UI has been proved [28], being the rate of sexual activity doubled.
Furthermore, an improvement of sexual variables is found in women with any type of UI who have performed pelvic floor muscle training, when compared with controls [29]. Probably, this positive impact on sexual life after treatment is due to, not only an improvement in the muscle function, but also an improvement of the UI symptoms, which minimyze its impact on sexuality.
It is also important to note that learning to coordinate pelvic floor muscles (voluntary contraction and relaxation) provides patients with control over a part of their bodies, which empowers them in their sexuality and can frequently constitute the door to work self-efficacy and self-esteem. A reduction in sexual problems of women with UI who perform pelvic floor muscle training has also been suggested by means of self-image improvement [30].
A meta-analysis has evaluated the impact on sexual function of overactive bladder associated to urgency UI, and also of its treatments measured by means of the FSFI questionnaire in the majority of studies [31]. In this systematic review, overactive bladder with UI (overactive bladder-wet) was reported to be the most important factor affecting women’s sexuality. A significant improvement of the overactive bladder associated to urgency UI and female sexual function, was described after anticholinergic, beta-adrenergic and botulinum toxin therapies. For this reason, authors conclude that women with overactive bladder associated with urgency UI and sexual dysfunction could benefit from a targeted therapy for UI symptoms. Frequently, fear or anxiety of feeling dirty or with bad smell make women with urgency UI incorporate adaptive maneuvers [6], such as urinating before and after partnered sexual activity, which influence how intimacy, proximity and partner dynamics are dealt with.
Possibly, the decrease in the urgency UI episodes with the treatment could also improve these more global aspects of the sexual life. In relation to this, Wang et al. [32] performed a study including 323 women with overactive bladder and demonstrated the effect of the severity of its symptoms on the rate of female sexual dysfunction and partners’ sexual satisfaction. When the different domains of the overactive bladder were analyzed, the urgency symptoms showed a significant effect on the female sexual function, as more severity of urgency UI has been associated with a higher rate of female sexual dysfunction [32]. In this way, UI was closely associated with partners’ sexual satisfaction [32]. Serati et al. [17] reported that the form of coital UI during orgasm is curable by antimuscarinic treatment in about 60% of cases when associated with detrusor overactivity.
Therefore, patients need to be informed in detail about the potential benefits in terms of improvement in the sexual function with urgency UI treatment.
A meta-analysis, including 22 studies, in which sexual function is evaluated after the collocation of retropubic and transobturator tension-free midurethral sling for the treatment of stress UI, confirms a significant improvement of the sexual function after stress UI surgical treatments. Results were evaluated in the mid-term (12–24 months after surgery) by means of the global score of the specific questionnaire PISQ-12 and the generic questionnaire FSFI and also by the 6 sexual dimensions of the FSFI questionnaire. A significant decrease by nearly 6-fold in the post-operative coital UI was also observed [33], being only based on 998 patients and 7 studies which assessed coital UI before and after surgery. A recent publication [34] specifically analysed the effect of retropubic tension-free midurethral sling for stress UI on coital UI. It was a prospective observational study conducted in women with urodynamic stress UI and concomitant coital UI. Among the 82 women who answered the post-operative Patient Global Impression-Improvement (PGI-I) scale for coital UI to assess the patient-reported success rate, in the pre-operative clinical assessment 58% stated they experienced UI during penetration, 15% during orgasm and 25% during both situations. After surgery, 86% reported being very much or much better in the evaluation, being the first study which shows the success rates after antiincontinence surgery according to each type of coital UI (91% in women with UI with penetration, 69% in women with orgasmic UI and 85% in women with both types of coital UI). In addition, a statistically significant improvement in the FSFI global sexual function score was found after the retropubic tension-free midurethral sling procedure. Therefore, according to these results, most of the women with stress UI and concomitant coital UI will improve their sexuality and, therefore, their quality of life after surgery.
Nevertheless, having performed a surgery in the anterior vaginal wall, anatomic, physiological, vascular, neurological and hormonal alterations can occur. Variations in this anatomical region could alter the vaginal sensitivity or vasocongestion by an affectation of its innervation, thus altering the female sexual function of a minority subgroup of women. Therefore, it is fundamental to evaluate women in the post-operative in order to detect in time possible complications of the antiincontinence techniques in the sexual sphere.
UI affects between one in four and one in two women, being stress UI the most prevalent type followed by mixed UI and urgency UI. Quality of life is negatively affected by UI, and also the physical, social, emotional and sexual wellbeing of the individual may be altered by it. All types of UI affect the sexual activity rate and the prevalence of sexual dysfunction within sexually active women with UI is high. Moreover, almost half of sexually active women with UI have coital UI. Treatments for UI such as conservative measures, medicines and surgery may have a positive impact on female sexuality.
Most of the research on sexual health in women with UI does not intend to identify the proportion of problems which are directly related to UI. For this reason, the measurement of the real impact of this dysfunction and its treatments on sexual health remains a complicated issue. Good quality investigation on sexual health in women with UI is required and it should be addressed to quantify the aspects of female sexual health which become affected by UI itself. This would lead to an improvement of the management strategies of these patients and the information being provided to them, which could comprise realistic expectations about the likely impact of the specific treatments.
SES and SAA designed the research study, performed the research, analyzed the data and wrote the manuscript. LRT and CCB provided advice on manuscript editing. All authors contributed to editorial changes in the manuscript. All authors read and approved the final manuscript.
Not applicable.
Thanks to all the peer reviewers for their opinions and suggestions.
This research received no external funding.
The authors declare no conflict of interest. CCB is serving as one of the Editorial Board members and Guest editors of this journal. We declare that CCB had no involvement in the peer review of this article and has no access to information regarding its peer review. Full responsibility for the editorial process for this article was delegated to MD.